Helena Jerkić
Research Subjects
Helena Jerkić has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Tomislav Letilović
Merkur" University Hospital, Zagreb, Croatia
15 shared publications - Darko Počanić13 shared publications
- Mario Stipinović11 shared publications
- Damir Kozmar9 shared publications
- Ivica Premužić Meštrović
Department of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
6 shared publications - Stjepan Kranjcevic6 shared publications
Latest Publications
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 544
A complex case of high-risk pulmonary embolism: mechanical thrombectomy, systemic thrombolysis and extracorporeal membrane oxygenation, all in one
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 544
A complex case of high-risk pulmonary embolism: mechanical thrombectomy, systemic thrombolysis and extracorporeal membrane oxygenation, all in one
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 547
Mitral annular disjunction as a risk factor for sudden cardiac death – a clinical case of a sudden cardiac death survivor with mitral annular disjunction
- 1 November 2024
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 19 (11-12) , 547
Mitral annular disjunction as a risk factor for sudden cardiac death – a clinical case of a sudden cardiac death survivor with mitral annular disjunction
- 1 September 2021
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 16 (9-10) , 289
Aortic balloon valvuloplasty as a bridge to liver transplantation in a patient with severe aortic stenosis and end-stage liver disease
- 1 September 2021
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 16 (9-10) , 289
Aortic balloon valvuloplasty as a bridge to liver transplantation in a patient with severe aortic stenosis and end-stage liver disease
- Open Access
- 21 May 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (20) , e26019
Cardiovascular mortality in liver and kidney transplant recipients
Previous studies have demonstrated cardiovascular causes to be among the leading causes of death after liver (LT) and kidney transplantation (KT). Although both recipient populations have unique pre-transplant cardiovascular burdens, they share similarities in post-transplant exposure to cardiovascular risk factors. The aim of this study was to compare cardiovascular mortality after LT and KT. We analyzed causes of death in 370 consecutive LT and 207 KT recipients from in-hospital records at a single tertiary transplant center. Cardiovascular causes of death were defined as cardiac arrest, heart failure, pulmonary embolism, or myocardial infarction. After a median follow-up of 36.5 months, infection was the most common cause of death in both cohorts, followed by cardiovascular causes in KT recipients and graft-related causes in LT recipients in whom cardiovascular causes were the third most common. Cumulative incidence curves for cardiovascular mortality computed with death from other causes as the competing risk were not significantly different (P = .36). While 1-year cumulative cardiovascular mortality was similar (1.6% after LT and 1.5% after KT), the estimated 4-year probability was higher post-KT (3.8% vs. 1.6%). Significant pre-transplant risk factors for overall mortality after KT in multivariable analysis were age at transplantation, left ventricular ejection fraction <50%, and diastolic dysfunction grade 2 or greater, while significant risk factors for cardiovascular mortality were peripheral artery disease and left ventricular ejection fraction <50%. In the LT group no variables remained significant in a multivariable model for either overall or cardiovascular mortality. The present study found no significant overall difference in cardiovascular mortality after LT and KT. While LT and KT recipients may have similar early cardiovascular mortality, long-term risk is potentially lower after LT. Differing characteristics of cardiovascular death between these two patient populations should be further investigated.
- 21 May 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (20) , e26019
Open AccessCardiovascular mortality in liver and kidney transplant recipients
Previous studies have demonstrated cardiovascular causes to be among the leading causes of death after liver (LT) and kidney transplantation (KT). Although both recipient populations have unique pre-transplant cardiovascular burdens, they share similarities in post-transplant exposure to cardiovascular risk factors. The aim of this study was to compare cardiovascular mortality after LT and KT. We analyzed causes of death in 370 consecutive LT and 207 KT recipients from in-hospital records at a single tertiary transplant center. Cardiovascular causes of death were defined as cardiac arrest, heart failure, pulmonary embolism, or myocardial infarction. After a median follow-up of 36.5 months, infection was the most common cause of death in both cohorts, followed by cardiovascular causes in KT recipients and graft-related causes in LT recipients in whom cardiovascular causes were the third most common. Cumulative incidence curves for cardiovascular mortality computed with death from other causes as the competing risk were not significantly different (P = .36). While 1-year cumulative cardiovascular mortality was similar (1.6% after LT and 1.5% after KT), the estimated 4-year probability was higher post-KT (3.8% vs. 1.6%). Significant pre-transplant risk factors for overall mortality after KT in multivariable analysis were age at transplantation, left ventricular ejection fraction <50%, and diastolic dysfunction grade 2 or greater, while significant risk factors for cardiovascular mortality were peripheral artery disease and left ventricular ejection fraction <50%. In the LT group no variables remained significant in a multivariable model for either overall or cardiovascular mortality. The present study found no significant overall difference in cardiovascular mortality after LT and KT. While LT and KT recipients may have similar early cardiovascular mortality, long-term risk is potentially lower after LT. Differing characteristics of cardiovascular death between these two patient populations should be further investigated.
- 1 October 2019
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 14 (9-10) , 232
Pretransplant echocardiographic findings as predictors of late adverse outcomes following liver and kidney transplantation
- 1 October 2019
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 14 (9-10) , 232
Pretransplant echocardiographic findings as predictors of late adverse outcomes following liver and kidney transplantation
- 5 April 2019
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 75 (3) , 205-211
Left atrium size and red cell distribution width predict atrial fibrillation progression from paroxysmal or persistent to permanent
Objective: Stratifying patients with paroxysmal or short-term persistent atrial fibrillation (AF) who are at greater risk of developing permanent AF is challenging. Aim of our prospective study was to evaluate association of laboratory parameters (biochemistry and complete blood count (CBC)) together with standard demographic, clinical and echocardiography parameters, with AF progression. Methods: We prospectively recruited 579 patients with AF and divided them into two groups at index hospitalization: paroxysmal or persistent (non-permanent AF), and long-term persistent or permanent AF patients (permanent AF). Clinical, echocardiographic, and relevant CBC parameters were collected. Non-permanent AF patients were selected for follow-up, with a median follow-up time of 21 months. Endpoint was progression to permanent AF. Results: Out of 409 patients with non-permanent AF, 109 (26.6%) progressed within follow-up. In a multivariate Cox regression model only increased left atrium (LA) diameter (HR 2.16, 95% CI 1.20–3.87, p = 0.010), and increased red cell distribution width (RDW; HR 1.19, 95% CI 1.03–1.39, p = 0.022) showed significant independent association with progression. There were 221/409 patients with both LA ≤45 mm and RDW level ≤14.5% who progressed at a rate of only 17.6%, and showed relative risk of AF progression of 0.47 (95% CI 0.34–0.67; p < 0,001). Conclusion: Together with LA size, RDW was independently associated with AF progression. Patients with both LA size ≤45 mm and RDW level ≤14.5% are most probably the best candidates for rhythm control strategies.
- 5 April 2019
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 75 (3) , 205-211
Left atrium size and red cell distribution width predict atrial fibrillation progression from paroxysmal or persistent to permanent
Objective: Stratifying patients with paroxysmal or short-term persistent atrial fibrillation (AF) who are at greater risk of developing permanent AF is challenging. Aim of our prospective study was to evaluate association of laboratory parameters (biochemistry and complete blood count (CBC)) together with standard demographic, clinical and echocardiography parameters, with AF progression. Methods: We prospectively recruited 579 patients with AF and divided them into two groups at index hospitalization: paroxysmal or persistent (non-permanent AF), and long-term persistent or permanent AF patients (permanent AF). Clinical, echocardiographic, and relevant CBC parameters were collected. Non-permanent AF patients were selected for follow-up, with a median follow-up time of 21 months. Endpoint was progression to permanent AF. Results: Out of 409 patients with non-permanent AF, 109 (26.6%) progressed within follow-up. In a multivariate Cox regression model only increased left atrium (LA) diameter (HR 2.16, 95% CI 1.20–3.87, p = 0.010), and increased red cell distribution width (RDW; HR 1.19, 95% CI 1.03–1.39, p = 0.022) showed significant independent association with progression. There were 221/409 patients with both LA ≤45 mm and RDW level ≤14.5% who progressed at a rate of only 17.6%, and showed relative risk of AF progression of 0.47 (95% CI 0.34–0.67; p < 0,001). Conclusion: Together with LA size, RDW was independently associated with AF progression. Patients with both LA size ≤45 mm and RDW level ≤14.5% are most probably the best candidates for rhythm control strategies.
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 315
Cardiovascular risk profile and adverse events in renal and liver transplant recipients
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 315
Cardiovascular risk profile and adverse events in renal and liver transplant recipients
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 342
Mortality and incidence of malignant arrhythmias in patients with dilated cardiomyopathy and implantable cardioverter defibrillator in primary and secondary prevention
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 342
Mortality and incidence of malignant arrhythmias in patients with dilated cardiomyopathy and implantable cardioverter defibrillator in primary and secondary prevention
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 338
Ablation therapy in heart failure: a single centre experience
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 338
Ablation therapy in heart failure: a single centre experience
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 317
Frequency and risk factors of adverse cardiovascular events in patients awaiting cardiac surgery
- 1 November 2018
- Published by Medicinska Naklada d.o.o. in Cardiologia Croatica
- Vol. 13 (11-12) , 317
Frequency and risk factors of adverse cardiovascular events in patients awaiting cardiac surgery